Previous Year's Programs

View speakers, slides, and presentations from previous year's symposiums.

6th Annual Diabetes Prevention Symposium

November 2023

The 6th Diabetes Prevention Symposium was held in-person on Thursday, November 9th and Friday, November 10th on the University of Colorado: Anschutz Medical Campus. This year's meeting covered the economics of T1D screening, practical considerations for T1D and other health screenings, and the priorities and challenges of population screening, amongst other topics. It also provided updates from current screening programs.

 Click on presentation title to view talk. Click on (Slides) to view presentation slides.

Please use this link for any questions\comments regarding this event

DAY 1

Thursday, November 9, 2023   10:00 am - 4:00 pm  
Barbara Davis Center, Main Conference Room 2104
1775 Aurora Court

SESSION 1: COST-EFFECTIVENESS OF POPULATION SCREENING FOR T1D

10:05-10:20    Health Economics of T1D Screening      (R. Brett McQueen, Denver, USA) (Slides)

10:20-10:35    Computational Framework for T1D Screening Optimization   (Gonçalo Leiria, Denver, USA) (Slides)

10:35-10:50    Comparison of T1D Risk Models              (Lauric Ferrat, Exeter, the U.K.) (Slides)

10:50-11:00    Panel Discussion  

SESSION 2: COMBINED SCREENING FOR T1D AND OTHER PEDIATRIC DISEASES

11:00-11:15    Scandinavian Perspective                    (Daniel Agardh, Malmo, Sweden) (Slides)

11:15-11:30    ASK Perspective                                      (Marisa Stahl and Edwin Liu, Aurora, USA) (Slides)

11:30-11:45    Early Check Study                                   (Lisa Gehtland, RTI International, Durham, USA) (Slides)

11:45-12:00    Panel Discussion  

12:00-12:30    Lunch

SESSION 3: PRACTICAL ASPECTS OF SCREENING FOR PRE-SYMPTOMATIC T1D

12:30-12:45   Lessons from ASK                                               (Crystal Silva and Cristy Geno Rasmussen, Denver) (Slides)

12:45-1:00     Stakeholders' Engagement in Screening      (Holly O'Donnell, Denver) (Slides)

1:00-1:15       Screening in Underserved Populations        (Sonja O'Leary, Denver)  (Slides)                 

1:15-1:30       EPIC customization                                            (Amber Corr and Brigitte Frohnert, Denver) (Slides)

1:30-1:45       Panel Discussion

1:45-2:00       Break

SESSION 4: PRACTICAL ASPECTS OF MONITORING AND EDUCATION IN PRE-SYMPTOMATIC T1D         

2:00-2:20       Monitoring Within a Health Care System    (Kurt Griffin, Sanford Health, Sioux Falls) (Slides)

2:20-2:40       Monitoring by a Tertiary Care Center          (Kim Bautista and Patricia Gesualdo, Denver) (Slides)

2:40-3:00       Enrollment into Clinical Trials                   (Hali Broncucia and Andrea Steck, Denver) (Slides)

3:00-3:20       Transition from Research to Clinical Care   (Lexie Chesshir and Kimber Simmons, Denver) (Slides)

3:20-4:00       Panel Discussion

DAY 2

Friday, November 10, 2023    8:00am - 4:40 pm  
Anschutz Health Sciences Building, Room 2010/2011
1890 North Revere Court

8:00-8:05       Welcome & Announcements   (Marian Rewers, Denver, USA) (Slides) 

SESSION 5: PRIORITIES AND CHALLENGES IN POPULATION SCREENING FOR T1D

8:05-9:00 Panel Discussion - Sanjoy Dutta and Esther Latres, JDRF, New YorkGina Agiostratidou and Anne Koralova, Helmsley Charitable Trust, New YorkBeena Akolkar, NIDDK, NIH, Bethesda

SESSION 6:  REPORTS FROM CURRENT GENERAL POPULATION SCREENING PROGRAMS

9:00-9:30        Fr1da and EDENT1FI                                      (Peter Achenbach, Munich, Germany) (Slides)

9:30-9:50       TRIAD & other Scandinavian programs    (Daniel Agardh, Malmo, Sweden) (Slides)

9:50-10:10     Australian National Screening Pilot         (Kirstine Bell, Sydney, Australia) (Slides)

10:10-10:30   CANscreen                                                       (Diane Wherrett, Toronto, Canada) (Slides)

10:30-10:45   Panel Discussion Part 1

10:45-11:00    Autoimmunity Screening for Kids (ASK)   (Cristy Geno Rasmussen, Denver, USA) (Slides)

11:00-11:15    T1Detect                                                            (Anastasia Albanese-O'Neill, JDRF, USA) (Slides)

11:15-11:30    PrIMeD: in-home screening for T1D          (Stephen Rich, Charlottesville, USA) (Slides)

11:30-11:45    PLEDGE, Sanford Health                               (Kurt Griffin, Sioux Falls, USA) (Slides)

11:45-12:00    CASCADE                                                            (William Hagopian, Seattle, USA) (Slides)

12:15-12:30    Panel Discussion Part 2

12:30-1:00      Lunch

SESSION 7: STANDARDIZATION OF IMMUNE MARKERS FOR SCREENING AND CONFIRMATION

1:00-1:20       Definition of Challenges                             (Peter Achenbach, Munich, Germany) (Slides)

1:20-1:40       IASP Perspective                                          (Vito Lampasona, Milan, Italy) (Slides)

1:40-2:00       Multiplexing                                                  (Liping Yu, Denver, USA) (Slides)

2:00-2:30       Panel Discussion 

2:30-2:45       Break

SESSION 8: GUIDELINES FOR MONITORING AND EDUCATION IN PRE-SYMPTOMATIC T1D

2:45-3:05       Consensus Building                                   (Linda DiMeglio, Indianapolis, USA) (Slides)

3:05-3:25       Monitoring of Children                             (Kimber Simmons, Denver, USA) (Slides)

3:25-3:45       Monitoring of Adults                                (Rifka Schulman-Rosenbaum, New York, USA) (Slides)

3:45-4:05       Education                                                    (Brigitte Frohnert, Denver, USA) (Slides) 

4:05-4:25       Psychological Support                             (Kimberly Driscoll, Gainesville, USA) (Slides)

4:25-4:40       Panel discussion

4:40               Closing Remarks                                         (Marian Rewers, Denver USA) (Slides)

This program was developed independently by the Barbara Davis Center for Diabetes and supported in part by educational grants from Sanofi US and the Children's Diabetes Foundation.